a year ago
TNYA
AnalystsJoseph PantginisJoseph Pantginis's Stock Forecasts
AnalystsJoseph Pantginis
Analyst Ranking
Top 17%
#877 out of 5226 analysts
Average Return
+0.91%
Win Rate
38%374 out of 972
Risk vs Reward
Poor
Good
Joseph Pantginis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Celldex Therapeutics IncCLDX | +1,183.78% | $1.85 | $23.75 | 2020-03-27 - 2021-03-26 | Buy |
Cidara Therapeutics IncCDTX | +938.85% | $21.31 | $221.38 | 2025-06-18 - 2026-01-06 | Buy |
Alpine Immune Sciences IncALPN | +694.86% | $8.17 | $64.94 | 2023-05-12 - 2024-05-10 | Buy |
Biomea Fusion IncBMEA | +644.47% | $4.79 | $35.66 | 2022-06-02 - 2023-06-01 | Buy |
Capricor Therapeutics IncCAPR | +501.06% | $2.84 | $17.07 | 2023-10-04 - 2024-10-03 | Buy |
Joseph Pantginis Analyst Color
Get additional color on Joseph Pantginis's coverage of popular stocks
a year ago
BLRX
a year ago
CAPR
2 years ago
VKTX
Joseph Pantginis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pharming Group NvPHAR | 18 | Buy | $37.00 | +131.68% | Reiterates | 21 hours ago |
Lineage Cell Therapeutics IncLCTX | 14 | Buy | $9.00 | +508.11% | Reiterates | 21 hours ago |
Lexicon Pharmaceuticals IncLXRX | 25 | Buy | $6.00 | +248.84% | Reiterates | 2 days ago |
Viking Therapeutics IncVKTX | 35 | Buy | $102.00 | +217.07% | Reiterates | 2 days ago |
Xoma Royalty CorpXOMA | 26 | Buy | $97.00 | +231.96% | Reiterates | 5 days ago |
Capricor Therapeutics IncCAPR | 28 | Buy | $60.00 | +107.83% | Reiterates | 12 days ago |
Q32 Bio IncQTTB | 1 | Buy | $13.00 | +78.08% | Initiates Coverage On | a month ago |
Ligand Pharmaceuticals IncLGND | 21 | Buy | $239.00 | +18.52% | Maintains | a month ago |
Fortress Biotech IncFBIO | 4 | Buy | $17.00 | +482.19% | Reiterates | a month ago |
Armata Pharmaceuticals IncARMP | 16 | Buy | $15.00 | +82.70% | Maintains | a month ago |
Adlai Nortye LtdANL | 4 | Buy | $16.00 | +128.90% | Upgrades | a month ago |
Aprea Therapeutics IncAPRE | 16 | Buy | $4.00 | +493.47% | Maintains | 2 months ago |
Tempest Therapeutics IncTPST | 20 | Buy | $11.00 | +528.57% | Upgrades | 2 months ago |
Kura Oncology IncKURA | 24 | Buy | $40.00 | +395.66% | Reiterates | 2 months ago |
Krystal Biotech IncKRYS | 33 | Buy | $310.00 | +25.46% | Reiterates | 3 months ago |
Cytokinetics IncCYTK | 47 | Buy | $136.00 | +126.59% | Maintains | 3 months ago |
Prokidney CorpPROK | 1 | Buy | $12.00 | +570.39% | Initiates Coverage On | 3 months ago |
Tenaya Therapeutics IncTNYA | 20 | Buy | $3.00 | +296.30% | Maintains | 3 months ago |
Neuphoria Therapeutics IncNEUP | 9 | Buy | $7.00 | +55.21% | Maintains | 4 months ago |
Fractyl Health IncGUTS | 3 | Buy | $8.00 | +1,760.47% | Reiterates | 4 months ago |
Shattuck Labs IncSTTK | 16 | Buy | $6.00 | -1.96% | Upgrades | 4 months ago |
Travere Therapeutics IncTVTX | 6 | Buy | $47.00 | +75.44% | Reiterates | 4 months ago |
Biomx IncPHGE | 17 | Buy | $26.00 | +434.98% | Reiterates | 4 months ago |
Pds Biotechnology CorpPDSB | 31 | Buy | $15.00 | +2,627.27% | Maintains | 4 months ago |
Iovance Biotherapeutics IncIOVA | 27 | Buy | $9.00 | +148.62% | Maintains | 5 months ago |
Newamsterdam Pharma Co NvNAMS | 1 | Buy | $52.00 | +72.99% | Assumes | 5 months ago |
Rigel Pharmaceuticals IncRIGL | 23 | Buy | $57.00 | +118.14% | Reiterates | 6 months ago |
Biocardia IncBCDA | 16 | Buy | $25.00 | +1,974.69% | Reiterates | 6 months ago |
Esperion Therapeutics IncESPR | 29 | Buy | $16.00 | +510.69% | Reiterates | 6 months ago |
Astria Therapeutics IncATXS | 23 | Buy | $20.00 | +58.98% | Maintains | 6 months ago |
Lisata Therapeutics IncLSTA | 18 | Buy | $15.00 | +198.80% | Reiterates | 7 months ago |
Celldex Therapeutics IncCLDX | 35 | Buy | $42.00 | +34.66% | Maintains | 7 months ago |
Sensei Biotherapeutics IncSNSE | 1 | Buy | $30.00 | +0.10% | Maintains | 8 months ago |
Nuvectis Pharma IncNVCT | 9 | Buy | $10.00 | +25.79% | Maintains | 8 months ago |
Edgewise Therapeutics IncEWTX | 1 | Buy | $42.00 | +37.08% | Initiates Coverage On | 9 months ago |
Phio Pharmaceuticals CorpPHIO | 2 | Buy | $14.00 | +1,047.54% | Reiterates | 9 months ago |
Cidara Therapeutics IncCDTX | 2 | Buy | $53.00 | -76.06% | Maintains | 9 months ago |
Actinium Pharmaceuticals IncATNM | 30 | Buy | $4.00 | +273.83% | Reiterates | 9 months ago |
Moleculin Biotech IncMBRX | 2 | Buy | $100.00 | +4,344.44% | Reiterates | 9 months ago |
Galectin Therapeutics IncGALT | 1 | Buy | $6.00 | +112.01% | Assumes | 9 months ago |
Biolinerx LtdBLRX | 13 | Buy | $26.00 | +974.38% | Reiterates | 9 months ago |
Gri Bio IncGRI | 3 | Buy | $280.00 | +11,422.63% | Reiterates | 9 months ago |
Atyr Pharma IncATYR | 23 | Buy | $35.00 | +4,330.38% | Reiterates | 10 months ago |
Curis IncCRIS | 1 | Buy | $17.00 | +2,277.62% | Assumes | 10 months ago |
Cadrenal Therapeutics IncCVKD | 5 | Buy | $32.00 | +458.46% | Reiterates | 10 months ago |
Calcimedica IncCALC | 12 | Buy | $16.00 | +2,476.49% | Reiterates | 10 months ago |
Kyntra Bio IncKYNB | 3 | Buy | $250.00 | +3,603.70% | Reiterates | 10 months ago |
Iterum Therapeutics PLCITRM | 1 | Buy | $9.00 | +5,257.14% | Assumes | a year ago |
Biomea Fusion IncBMEA | 29 | Buy | $18.00 | +1,492.92% | Maintains | a year ago |
Vyne Therapeutics IncVYNE | 20 | Buy | $4.50 | +643.80% | Maintains | a year ago |
Compass Therapeutics IncCMPX | 18 | Buy | $24.00 | +350.28% | Reiterates | a year ago |
Clene IncCLNN | 29 | Buy | $31.00 | +441.01% | Reiterates | a year ago |
Kairos Pharma LtdKAPA | 1 | Buy | $12.00 | +1,807.79% | Initiates Coverage On | a year ago |
Aptose Biosciences IncAPTOF | 15 | Buy | $6.00 | +250.88% | Maintains | a year ago |
Omniab IncOABI | 7 | Buy | $11.00 | N/A | Reiterates | a year ago |
Checkpoint Therapeutics IncCKPT | 17 | Hold | $4.10 | N/A | Downgrades | a year ago |
Palatin Technologies IncPTN | 27 | Buy | $7.00 | N/A | Maintains | a year ago |
Genenta Science SpaGNTA | 4 | Buy | $25.00 | N/A | Reiterates | a year ago |
Biora Therapeutics IncBIOR | 9 | Buy | $150.00 | N/A | Reiterates | 2 years ago |
Mustang Bio IncMBIO | 6 | Buy | $100.00 | N/A | Reiterates | 2 years ago |
Panbela Therapeutics IncPBLA | 8 | Buy | $5.00 | N/A | Maintains | 2 years ago |
Alpine Immune Sciences IncALPN | 7 | Buy | $50.00 | N/A | Maintains | 2 years ago |
Traws Pharma IncTRAW | 9 | Buy | $11.00 | N/A | Reiterates | 2 years ago |
Biophytis SaBPTSY | 5 | Buy | $600.00 | N/A | Reiterates | 3 years ago |
Decibel Therapeutics IncDBTX | 5 | Buy | $23.00 | N/A | Reiterates | 3 years ago |
Atreca IncBCEL | 5 | Buy | $25.00 | N/A | Reiterates | 3 years ago |
Aravive IncARAV | 9 | Buy | $12.00 | N/A | Reiterates | 3 years ago |
Xenetic Biosciences IncXBIO | 3 | Buy | $40.00 | N/A | Reiterates | 3 years ago |
IMV IncIMVIQ | 1 | Buy | $65.00 | N/A | Reiterates | 3 years ago |
Applied Genetic Technologies CorpAGTC | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Akouos IncAKUS | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Humanigen IncHGENQ | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Genocea Biosciences IncGNCAQ | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Sierra Oncology IncSRRA | 1 | Hold | $55.00 | N/A | Downgrades | 4 years ago |
Sio Gene Therapies IncSIOX | 3 | Buy | $7.00 | N/A | Maintains | 4 years ago |
Beyondspring IncBYSI | 4 | Hold | N/A | N/A | Downgrades | 4 years ago |
Essa Pharma IncEPIX | 3 | Buy | $32.00 | N/A | Maintains | 5 years ago |
Strata Skin Sciences IncSSKN | 1 | Buy | $30.00 | N/A | Upgrades | 5 years ago |
Principia Biopharma IncPRNB | 4 | Hold | $100.00 | N/A | Downgrades | 6 years ago |
Avid Bioservices IncCDMO | 2 | Buy | $9.00 | N/A | Reiterates | 6 years ago |
Immune Design CorpIMDZ | 1 | Buy | $7.75 | N/A | Maintains | 7 years ago |
Tg Therapeutics IncTGTX | 2 | Buy | $33.00 | N/A | Assumes | 8 years ago |
Soligenix IncSNGX | 1 | Buy | $2,640.00 | N/A | Initiates Coverage On | 9 years ago |
Palvella Therapeutics IncPVLA | 1 | Strong Buy | $720.00 | N/A | Initiates Coverage On | 9 years ago |
Verastem IncVSTM | 1 | Buy | $78.00 | N/A | Reiterates | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.